INSM - Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.

52W High

$146.84

52W Low

$60.40

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.97

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-6.05

EV/Revenue (<3 favorable)

73.82

P/S (TTM) (<3 favorable)

77.04

P/B (<3 favorable)

24.54

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.65%

Institutions (25–75% balanced)

101.28%

Shares Outstanding

211,375,000

Float

190,457,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

398,105,000

Gross Profit (TTM)

301,431,000

EPS (TTM)

-5.67

Profit Margin (>10% good)

-2.60%

Operating Margin (TTM) (higher better)

-2.36%

ROE (TTM) (>15% strong)

-1.61%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.19

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—